FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
Therapeutic strategies against cancer cachexia
3486Downloads: 2019HTML: 435 -
Oxy-inflammation in hyperbaric oxygen therapy applications
1607Downloads: 820HTML: 19 -
A mini-review of TAT-MyoD fused proteins: state of the art and problems to solve
1419Downloads: 774HTML: 204 -
44 | Targeted delivery of mir-486 to skeletal muscle: efficacy, tropism, and integrin dependency of MYOAAV2A vs. AAV9 Chiara Ricciardi1, S. Perni1, V. Sorrentino1|2 | 1Department of Molecular and Developmental Medicine, University of Siena, Italy; 2Interdepartmental Program of Molecular Diagnosis and Pathogenetic Mechanisms of Rare Genetic Diseases, Azienda Ospedaliera Universitaria Senese, Italy.
247 -
Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia
3869Downloads: 1868HTML: 203 -
31 | Exon skipping peptide-conjugated morpholinos downregulate dynamin 2 to rescue centronuclear myopathy Foteini Moschovaki-Filippidou1, J. de Carvalho Neves1, N. Diedhiou1, Y. Jad2|3, J. Böhm1, M.J.A. Wood2|3, M.A. Varela2|3, J. Laporte1 | 1IGBMC (Institut de Génétique et de Biologie Moléculaire et Cellulaire), Inserm U1258, CNRS UMR7104, Université de Strasbourg, Illkirch, France; 2Department of Paediatrics, Institute of Developmental and Regenerative Medicine (IDRM), University of Oxford, UK; 3MDUK Oxford Neuromuscular Centre, Oxford, UK.
190 -
Novel management of glioma by molecular therapies, a review article
1535Downloads: 846HTML: 43 -
Increasing autophagy does not affect neurogenic muscle atrophy
2336Downloads: 1149HTML: 110 -
Do neurogenic and cancer-induced muscle atrophy follow common or divergent paths?
1265Downloads: 783HTML: 45
1 - 42 of 42 items